4
Changes in Ownership
AbCellera Biologics Inc. Filed Acc 0000899243-20-034349
Director acquired 29,105,761 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HAMER JOHN Director | 2020-12-15 | Conversion | +29,076,350 | 29,076,350 | I | ||
| HAMER JOHN Director | 2020-12-15 | Conversion | +29,411 | 29,105,761 | I | ||
| Derivatives | |||||||
| HAMER JOHN Director | 2020-12-11 | Grant or award · Convertible Note | +0 | $500,000.00 | $0 | I | |
| HAMER JOHN Director | 2020-12-15 | Conversion · Series A1 Preferred Shares | −2,105,264 | 0 | I | ||
| HAMER JOHN Director | 2020-12-15 | Conversion · Series A2 Preferred Shares | −802,371 | 0 | I | ||
| HAMER JOHN Director | 2020-12-15 | Conversion · Convertible Note | −0 | 0 | I | ||
Loading xslF345X03/doc4.xml…